YAN, G.,
ZHANG, L.,
FENG, C.,
GONG, R.,
HUANG, Q.,
HE, M.,
YANG, F.,
LI, Y.,
DING, F.,
MA, W.,
HAN, Z.,
WANG, Z.,
YUAN, Y.,
CAI, B.,
YANG, L.,
GUO, S.,
V.N. Pavlov,
XU, C.,
IDIIATULLINA, E (2018) strategies for
several diseases. However, the blue LED
effects remain largely unknown in colorectal cancer
AKHMADIEV, N.S.,
AKHMETOVA, V.R.,
IBRAGIMOV, A.G.,
GALIMOVA, A.M.,
GALIMOVA, R.A.,
AGLETDINOV, E.F.,
KATAEV, V.A.,
KHAIRULLINA, V.R. (2019) providing a basis for the therapeutic
effects of five-membered palladacycles (as mixture of stereoisomers
LIU, Z.,
ZHANG, R.,
CHEN, X.,
YAO, P.,
YAN, T.,
LIU, W.,
YAO, J.,
ZHAO, S.,
SOKHATSKII, A.,
GAREEV, I. (2019) -molecule compounds with potential therapeutic
effects. Finally, we verified the expression levels of the hub genes
LV, L.,
ZHANG, L.,
LI, R.,
LI, Y.,
YANG, R.,
LI, C.,
FANG, R.,
SHABANOVA, A.,
LI, X.,
LIU, Y.,
LIANG, H.,
ZHOU, Y.,
SHAN, H.,
ZHENG, N. (2020) therapies and drugs have a good
effect on cardiac conduction delay. Metformin (Met) has a protective
effectBogliolo, M.,
Catucci, I.,
Caleca, L.,
Lasheras, S.V.,
Pujol, R.,
Kiiski, J.I.,
Muranen, T.A.,
Barnes, D.R.,
Dennis, J.,
Michailidou, K.,
Bolla, M.K.,
Leslie, G.,
Figlioli, G. (2019) , with greater
effects for the ER-negative and triple-negative breast cancer (TNBC) subtypes. We tested the three
Baltina, L.A.,
Hour, M.-J.,
Liu, Y.-C.,
Chang, Y.-S.,
Huang, S.-H.,
Lai, H.-C.,
Kondratenko, R.M.,
Petrova, S.F.,
Yunusov, M.S.,
Lin, C.-W. (2021) assays on the cytopathic
effect (CPE) and viral infectivity of ZIKV in three different human cell lines
major
effects are reported in the case of vinn ≠ vout analyzed here. (i) Due to the difference
Bikbov, M.M.,
Nikitin, N.A.,
Surkova, V.K.,
Farkhutdinov, R.R.,
Khalilov, L.M.,
Tulyabaev, A.R.,
Nikitina, A.F.,
Fedoreev, S.A.,
Mishchenko4, N.P. (2018) for histochrome in tests of the duration of the in vitro antioxidant
effect. PMR measurements proved that a β